Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A model for gastric banding in the treatment of morbid obesity: the effect of chronic partial gastric outlet obstruction on esophageal physiology.
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells.
In vivo intracranial pressure dynamics in patients with hydrocephalus treated by shunt placement.
Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancer.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancer.
Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancer. Nat Commun. 2019 12 06; 10(1):5604.
View in:
PubMed
subject areas
Animals
Carcinoma, Non-Small-Cell Lung
Cell Line, Tumor
Glucose
Glutathione
Glycolysis
Humans
Inactivation, Metabolic
Lactoylglutathione Lyase
Lung
Lung Neoplasms
Male
Metabolomics
Mice
Mice, Inbred C57BL
Pyruvaldehyde
authors with profiles
Brandon Faubert